Chemopreventive activities of C-glucuronide/glycoside analogs of retinoid-o-glucuronides against breast cancer development and growth

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 757-764

  Curley Jr , R W ^a   Abou Issa, H ^a   Panigot, M J ^a   Repa, J J ^b   Clagett Dame, M ^b   Alshafie, G ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Breast cancer; Cancer chemoprevention; Retinoid glucuronides; Retinoids

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; FENRETINIDE; GLUCURONIDE; GLYCOSIDE; RETINOIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER MODEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG STABILITY; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FENRETINIDE; GLUCURONATES; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 0030008514     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Abau-Issa H, Curley RW, Panigot MJ, Wilcox KA and Webb TE: In vivo use of N-(4-hydroxyphenyl)retinamide-O-glucuronide as a breast cancer chemopreventive agent. Anticancer Res 13: 1431-1436, 1993.
2. Meata RG, Barua AB, Olson JA and Moon RC Effect of retinoid glucuronides on mammary gland development in organ culture. Oncology 48: 505-509, 1991.
3. Ziae MH, Cullum ME, Simpson RU, Barua AB and Swartz DA: Induction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl glucuronide, a biologically active metabolite of vitamin A. Proc Natl Acad Sci USA 84: 2208-2212, 1987.
4. Roaarge MJ, Repa JJ, Hanson KK, Seth S, Clagett-Dame M, Aboulssa H and Curley RW: N-linked analogs of retinoid O-glucuronides; potential cancer chemopreventive/chemotherapeutic agents Bioorg Med Chem Lett 4: 2117-2122, 1994.
5. Barua AB and Olson JA: The chemical synthesis and characterization of retinoyl ß-glucuronide. Fed Proc Fed Am Soc Exp Biol 44: 772, 1985.
6. Siatsema WK and DeLuca HF: A new vaginal smear assay for Vitamin A in rats. J Nutr 112: 1481-1489, 1982.
7. Gaalup J, Barua A, Furr A and Olson JA: Effects of retinoid-ß-glucuronides and N-retinoyl amines on the differentiation of HL-60 cells in vitro. Proc Soc Exptl Biol Med 186: 269-274, 1987.
8. Guaning DB, Barua AB and Olson JA: Comparative teratogenicity and metabolism of all-trans retinoic acid, all-trans retinoyl ß-glucose, and all-trans retinoyl ß-glucuronide in pregnant Sprague-Dawley rats. Teratology 47: 29-36, 1993.
9. Bhatnagar R, Abou-Issa H, Curley RW, Koolemans-Beynen A, Moeschberger M and Webb TE: Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide, its glucuronide and through synergism with glucarate. Biochem. Pharmacol. 41: 1471-1477, 1991.
10. Paaigot MJ, Humphries KA and Curley RW: Preparation of 4-retinamidophenyl-and 4-retinamidobenzyl-C-glycosyl and C-glucuronosyl analogues of the glucuronide of 4-hydroxyphenyl-retinamide as potential cancer chemopreventive agents. J Carbohydr Chem 13: 303-321, 1984.
11. Abau-Issa H, Duruibe V, Minton JP, Larroya S, Dwivedi C and Webb TE: Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz(a)anthracene. Proc Natl Acad Sci USA 85: 4181-4184, 1988.
12. Abau-Issa H, Webb TE, Minton JP and Moeschberger M: Chemotherapeutic evaluation of glucarate: N-(4-hydroxyphenyl)-retinamide combination in the rat mammary tumor model. J Natl Cancer Inst 81: 1820-1823, 1989.
13. Ueaa H, Takenawa T, Millman JC, Gerell MS, Brandes D: The effect of retinoids on proliferative capacities and macromolecular synthesis in human breast cancer MCF-7 cells. Cancer Res 40: 2203-2209, 1980.
14. Reaa JJ, Hanson KK and Clagett-Dame M: All-trans-retinol is a ligand for the retinoic acid receptors. Proc Natl Acad Sci USA 90: 7293-7297, 1993.
15. Koarner TJ, Hill JE, Myers AM and Tzagoloff A: High expression vectors with multiple cloning sites for construction of trpE fusion genes: pATH vectors. Meth Enzymol 194: 477-490, 1991.
16. Wialiams D and Gorski J: Equilibrium binding of estradiol by uterine cell suspensions and whole uteri in vitro. Biochemistry 13: 5537-5542, 1974.
17. 3 receptor on sodium dodecyl-sulfate/polyacrylamide gels by renaturation and immunoblotting. Proc Natl Acad Sci USA 82: 7825-7829, 1985.
18. Muason PJ and Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239, 1980.
19. Woalson RF: Statistical methods for the analysis of biomedical data. New York, John Wiley and Soas, 1987, pp 327-337.
20. McCormick D, Burns F and Alberts R: Inhibition of rat mammary carcinogenesis by short dietary exposure to retinyl acetate. Cancer Res 40: 1140-1143, 1980.
21. Giauere V: Retinoic acid receptors and cellular retinoid binding proteins; complex interplay in retinoid signalling. Endocrine Revs 15. 61-79, 1994.
22. Saai BP, Barua AB, Hill DL, Shih T-W and Olson JA: Retinoyl ß-glucuronide: lack of binding to receptor proteins of retinoic acid as related to biological activity. Biochem Pharmacol 43: 919-922, 1992.
23. Foamelli F, Cassana R, Costa A, Buranelli F, Campa T, Dossena G, Magni A and Pizzichetta, M: Plasma retinol level reduction by the synthetic retinoid fenretinide: A one year follow-up study of breast cancer patients. Cancer Res 49: 6149-6152, 1989.
24. Shah T-W, Shealy YF and Hill DL: Enzymatic hydrolysis of retinamides. Drug Metab Disp 76: 337-340, 1988.
25. Huatin TA, May CM and Moon RC. N-(4-Hydroxyphenyl)-all-all-transretinamide pharmacokinetics in female rats and mice. Drug Metab Disp 14: 714-717, 1986.
26. Deaia D, Aiello A, Lombardi L, Pelicci PG, Grignani, F, Formelli F, Menard S, Costa A, Veronesi U and Pierotti MA: N-(4-Hydroxyphenyl)retinamide induces apoptosis of malignant hematopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 53: 6036-6041, 1992.
27. Abau-Issa H, Dwivedi C, Curley RW, Kirkpatrick R, Koolemans-Beynen A, Engineer F, Humphries KA, El-Masry W and Webb TE: Basis for the antitumor and chemopreventive activities of glucarate and the glucarate: retinoid combination. Anticancer Res 13: 395-400, 1993.
28. Abau-Issa H and Duruibe V: Anticarcinogenic effect of retinoids on 7,12-dimethylbenz(a)anthracene-induced mammary tumor induction and its relationship to cyclic AMP-dependent protein kinase. Biochem Biophys Res Communt 135: 116-123, 1986.